期刊文献+

Pitavastatin attenuates AGEs-induced mitophagy via inhibition of ROS generation in the mitochondria of cardiomyocytes 被引量:7

Pitavastatin attenuates AGEs-induced mitophagy via inhibition of ROS generation in the mitochondria of cardiomyocytes
下载PDF
导出
摘要 This study aimed to investigate whether pitavastatin protected against injury induced by advanced glycation end products products(AGEs) in neonatal rat cardiomyocytes,and to examine the underlying mechanisms.Cardiomyocytes of neonatal rats were incubated for 48 hours with AGEs(100 μg/mL),receptor for advanced glycation end products(RAGE),antibody(1 μg/mL) and pitavastatin(600 ng/mL).The levels of p62 and beclinl were determined by Western blotting.Mitochondrial membrane potential(△Ψm) and the generation of reactive oxygen species(ROS) were measured through the JC-1 and DCFH-DA.In the AGEs group,the expression of beclinl was remarkably increased compared to the control group,while the expression of p62 was significantly decreased.AGEs also markedly decreased △Ψm and significantly increased ROS compared with the control group.After treatment with RAGE antibody or pitavastatin,the level of beclinl was markedly decreased compared with the AGEs group,but the level of p62 was remarkably increased.In the AGEs + RAGE antibody group and AGEs+ pitavastatin group,△Ψm was significantly increased and ROS was remarkably decreased compared with the AGEs group.In conclusion,AGEs-RAGE may induce autophagy of cardiomyocytes by generation of ROS and pitavastatin could protect against AGEs-induced injury against cardiomyocytes. This study aimed to investigate whether pitavastatin protected against injury induced by advanced glycation end products products(AGEs) in neonatal rat cardiomyocytes,and to examine the underlying mechanisms.Cardiomyocytes of neonatal rats were incubated for 48 hours with AGEs(100 μg/mL),receptor for advanced glycation end products(RAGE),antibody(1 μg/mL) and pitavastatin(600 ng/mL).The levels of p62 and beclinl were determined by Western blotting.Mitochondrial membrane potential(△Ψm) and the generation of reactive oxygen species(ROS) were measured through the JC-1 and DCFH-DA.In the AGEs group,the expression of beclinl was remarkably increased compared to the control group,while the expression of p62 was significantly decreased.AGEs also markedly decreased △Ψm and significantly increased ROS compared with the control group.After treatment with RAGE antibody or pitavastatin,the level of beclinl was markedly decreased compared with the AGEs group,but the level of p62 was remarkably increased.In the AGEs + RAGE antibody group and AGEs+ pitavastatin group,△Ψm was significantly increased and ROS was remarkably decreased compared with the AGEs group.In conclusion,AGEs-RAGE may induce autophagy of cardiomyocytes by generation of ROS and pitavastatin could protect against AGEs-induced injury against cardiomyocytes.
出处 《The Journal of Biomedical Research》 CAS CSCD 2018年第4期281-287,共7页 生物医学研究杂志(英文版)
基金 supported by the National NaturalScience Foundation of China(NSFC 81570328,Wang Junhong) the"Sixth-Peak Talent"of Jiangsu Province(2011WSN-029 to Prof.Guo Yan and2013WSN-036 to Dr.Wang Junhong) support by the Health Department of Jiangsu Province(z201301)
关键词 advanced glycation end products(AGEs) receptor for advanced glycation end products(RAGE) PITAVASTATIN autophagy mitochondrial oxidation oxidative stress advanced glycation end products(AGEs) receptor for advanced glycation end products(RAGE) pitavastatin autophagy mitochondrial oxidation oxidative stress
  • 相关文献

二级参考文献23

  • 1李永强,马虹,董吁钢.肺炎衣原体感染增强C57BL/6J小鼠氧化应激加速动脉粥样硬化发展[J].中华心血管病杂志,2005,33(5):395-398. 被引量:2
  • 2Ivanov MV, Voskresenskaia ON, Zakharova NB.Indicators of endothelial dysfunction and apoptosis in chronic brain ischemia caused by arterial hypertension[J].Zh Nevrol Psikhiatr Im S S Korsakova, 2009, 109:71-72.
  • 3Tesauro M, Leo R, Lauro R, et al.Endothelial dysfunction and diabetes: possible role in kidney damage[J].G Ital Nefrol, 2009, 26 Suppl 46:62-70.
  • 4de la Sierra A, Larrousse M.Endothelial dysfunction is associated with increased levels of biomarkers in essential hypertension[J].J Hum Hypertens, 2010, 24:373-379.
  • 5Cozma A, Or??an O, Sampelean D, et al.Endothelial dysfunction in metabolic syndrome[J].Rom J Intern Med, 2009, 47:133-140.
  • 6Bernatova I, Conde MV, Kopincova J, et al.Endothelial dysfunction in spontaneously hypertensive rats: focus on methodological aspects[J].J Hypertens Suppl, 2009, 27:S27-S31.
  • 7Cybulsky MI, Gimbrone MA Jr.Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis[J].Science, 1991, 251:788-791.
  • 8Sun HX, Zeng DY, Li RT, et al.Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase[J].Hypertension, 2012, 60:1407-1414.
  • 9Yang JC, Huang F, Wu CJ, et al.Simvastatin reduces VCAM-1 expression in human umbilical vein endothelial cells exposed to lipopolysaccharide[J].Inflamm Res, 2012, 61:485-491.
  • 10Suh JW, Choi DJ, Chang HJ, et al.HMG-CoA reductase inhibitor improves endothelial dysfunction in spontaneous hypertensive rats via down-regulation of caveolin-1 and activation of endothelial nitric oxide synthase[J].J Korean Med Sci, 2010, 25:16-23.

共引文献12

同被引文献11

引证文献7

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部